#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12264	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2064	590.0	0	.	n	.	0	C1450T	SNP	1450	1450	C	1650	1650	T	659	T	578	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12264	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2064	590.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1384	1384	C	748	C	678	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22532	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3553	632.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1688	1688	A	772	A	695	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22532	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3553	632.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2322	2322	C	719	C,G	632,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22532	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3553	632.4	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2948	2948	T	723	T,A	653,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22532	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3553	632.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2396	2396	A	726	A	663	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1468	folP	852	852	93.78	folP.l15.c4.ctg.1	1473	99.5	0	.	p	.	0	G5V	NONSYN	13	15	GGT	316	318	GTT	104;105;105	G;T;T	92;92;93	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1468	folP	852	852	93.78	folP.l15.c4.ctg.1	1473	99.5	0	.	p	.	0	E12K	NONSYN	34	36	GAA	337	339	AAA	128;130;131	A;A;A	112;113;116	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1468	folP	852	852	93.78	folP.l15.c4.ctg.1	1473	99.5	0	.	p	.	0	F31L	NONSYN	91	93	TTT	394	396	TTG	154;152;154	T;T;G	142;140;141	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1468	folP	852	852	93.78	folP.l15.c4.ctg.1	1473	99.5	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	427	429	CAA	194;194;193	C;A;A	178;179;179	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1468	folP	852	852	93.78	folP.l15.c4.ctg.1	1473	99.5	0	.	p	.	0	S75P	NONSYN	223	225	TCC	526	528	CCT	174;175;178	C,T;C;T	155,1;157;158	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1468	folP	852	852	93.78	folP.l15.c4.ctg.1	1473	99.5	0	.	p	.	0	V87A	NONSYN	259	261	GTA	562	564	GCA	145;142;140	G,T;C;AG,A	134,1;132;120,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1468	folP	852	852	93.78	folP.l15.c4.ctg.1	1473	99.5	0	.	p	.	0	V130L	NONSYN	388	390	GTC	691	693	CTC	166;169;172	C;T;C	148;147;153	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1468	folP	852	852	93.78	folP.l15.c4.ctg.1	1473	99.5	0	.	p	.	0	R135C	NONSYN	403	405	CGC	706	708	TGT	168;170;169	T;G;T	139;147;137	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1468	folP	852	852	93.78	folP.l15.c4.ctg.1	1473	99.5	0	.	p	.	0	T137A	NONSYN	409	411	ACG	712	714	GCG	164;164;160	G;C;G	142;137;137	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1468	folP	852	852	93.78	folP.l15.c4.ctg.1	1473	99.5	0	.	p	.	0	E151K	NONSYN	451	453	GAA	754	756	AAG	178;178;182	A;A;G	163;165;167	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1468	folP	852	852	93.78	folP.l15.c4.ctg.1	1473	99.5	0	.	p	.	0	T152N	NONSYN	454	456	ACC	757	759	AAT	181;184;180	A;A;T	167;170;168	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1468	folP	852	852	93.78	folP.l15.c4.ctg.1	1473	99.5	0	.	p	.	0	F218L	NONSYN	652	654	TTT	955	957	TTG	117;116;115	T;T;G	113;111;110	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1468	folP	852	852	93.78	folP.l15.c4.ctg.1	1473	99.5	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	985	987	AGC	97;98;98	A;G;C	91;91;92	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1468	folP	852	852	93.78	folP.l15.c4.ctg.1	1473	99.5	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1054	1056	CTG	95;93;92	C;T;G	87;79;82	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1468	folP	852	852	93.78	folP.l15.c4.ctg.1	1473	99.5	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1060	1062	TCC	91;91;91	T;C;C	87;85;88	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1468	folP	852	852	93.78	folP.l15.c4.ctg.1	1473	99.5	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1075	1077	GTG	107;108;110	G;T;G,A	93;88;93,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1468	folP	852	852	93.78	folP.l15.c4.ctg.1	1473	99.5	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1126	1128	GCG	134;133;130	G;C;G	120;121;118	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4990	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3329	149.6	1	SNP	p	S91F	0	.	.	271	273	TCC	543	545	TCC	157;157;157	T;C;C,A	137;138;137,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4990	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3329	149.6	1	SNP	p	D95N	0	.	.	283	285	GAC	555	557	GAC	157;157;160	G;A,T;C	143;143,1;146	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4990	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3329	149.6	1	SNP	p	D95G	0	.	.	283	285	GAC	555	557	GAC	157;157;160	G;A,T;C	143;143,1;146	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	531	1490	mtrR	633	633	99.68	mtrR.l15.c30.ctg.1	1444	103.0	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	753	753	T	195	T,C	169,2	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	698	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	922	75.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4452	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3039	146.3	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1545	1547	ATC	156;157;157	A;T;C	136;138;138	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4452	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3039	146.3	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1698	1700	GCA	177;176;178	G;C;A	157;152;153	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4452	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3039	146.3	1	SNP	p	D86N	0	.	.	256	258	GAC	651	653	GAC	191;197;199	G,T;A;C	168,1;173;179	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4452	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3039	146.3	1	SNP	p	S87W	0	.	.	259	261	AGT	654	656	AGT	199;198;199	A;G;T	179;177;178	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4452	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3039	146.3	1	SNP	p	S87I	0	.	.	259	261	AGT	654	656	AGT	199;198;199	A;G;T	179;177;178	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4452	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3039	146.3	1	SNP	p	S87R	0	.	.	259	261	AGT	654	656	AGT	199;198;199	A;G;T	179;177;178	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4452	parC	2304	2304	99.74	parC.l6.c4.ctg.1	3039	146.3	1	SNP	p	S88P	0	.	.	262	264	TCC	657	659	TCC	198;199;204	T;C;C	176;178;180	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4038	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2801	144.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1633	1635	GGC	187;189;185	G;G;C	170;171;168	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	3530	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2296	153.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1228	1230	GCA	210;211;211	G;C;A	179;183;184	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3530	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2296	153.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1231	1233	ATC	211;210;210	A;T,A;C	182;181,1;178	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3530	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2296	153.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1243	1245	GTG	212;213;214	G;T;G	184;182;184	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3530	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2296	153.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1243	1245	GTG	212;213;214	G;T;G	184;182;184	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3530	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2296	153.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1747	1749	ACC	174;174;175	A;C;C	160;160;163	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3530	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2296	153.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1801	1803	GCG	172;172;174	G;C;G	150;129;146	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3530	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2296	153.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1801	1803	GCG	172;172;174	G;C;G	150;129;146	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3530	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2296	153.1	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1924	1926	GGT	171;172;172	G;G;T	151;152;151	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3530	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2296	153.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1933	1935	GGC	165;164;163	G,T;G;C	142,1;141;141	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	3530	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2296	153.1	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1951	1953	CCG	144;150;151	C,G;C,G;G	103,5;106,2;105	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5158	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3086	166.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1964	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1783	109.6	0	.	p	.	0	S22G	NONSYN	64	66	AGC	274	276	GGC	136;133;134	G;G;C	122;120;120	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1964	porA	1146	1146	99.74	porA.l15.c4.ctg.1	1783	109.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	456	456	C	134	C	120	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2474	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1669	147.8	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	954	954	T	203	T,A	179,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2474	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1669	147.8	1	SNP	p	G120K	0	.	.	358	360	GGT	681	683	GGT	210;210;212	G;G;T	195;193;188	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2474	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1669	147.8	1	SNP	p	A121N	0	.	.	361	363	GCC	684	686	GCC	214;216;218	G;C;C	195;195;200	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2474	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	1669	147.8	1	SNP	p	A121D	0	.	.	361	363	GCC	684	686	GCC	214;216;218	G;C;C	195;195;200	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9324	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	4860	191.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	932	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1020	91.2	1	SNP	p	V57M	1	.	.	169	171	ATG	543	545	ATG	200;199;196	A;T;G	180;179;178	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
